|
State
Drug Administration Order
Number 16
The Provisions on
Medical Device Registration were examined and passed by the State
Drug Administration on March 27, 2000 and shall go into effect April
10, 2000.
Director General:
Zheng Xiaoyu
April
5, 2000
Provision on
Medical Device Registration
Chapter
I. General Principles
Article
1 These
provisions were formulated in accordance with Regulations for the
Supervision and Administration of Medical Device to regulate the
registration and management of medical device and ensure the safety
and effectiveness of medical device.
Article
2 All
medical devices for sale and use within the borders of China must be
registered in accordance with the provisions. Any such equipment or
supplies that have not been so registered must not be sold or used
in China.
Article
3 Medical
devices shall be registered by classification in China.
Registration
application of Class I medical devices manufactured by domestic
enterprises shall be inspected by the Drug Administration of the
municipalities consisting of districts. A registration certificate
shall be issued for the product upon approval.
Registration
application of Class II medical devices manufactured by domestic
enterprises shall be inspected by the Drug Administration of
provincial level. A registration certificate shall be issued for the
product upon approval.
Registration
application of Class III medical devices manufactured by domestic
enterprises shall be inspected by the State Drug Administration. A
registration certificate shall be issued for the product upon
approval.
Registration
application of medical devices manufactured by overseas enterprises
shall be inspected by the State Drug Administration. A registration
certificate shall be issued for the product upon approval.
Medical
devices manufactured by domestic enterprises refer to those products
of which the final manufacturing processes are completed within the
borders of China.
Medical
devices manufactured by overseas enterprises refer to products of
which the final manufacturing processes are completed outside the
borders of China.
The
registration of products made in Taiwan, Hongkong and Macao for sale
and use within the borders of Mainland China shall be inspected by
the State Drug Administration. A registration certificate shall be
issued upon approval.
Article
4 Medical
device registration certificates shall be printed uniformly by the
State Drug Administration.
(1)
Class I products by domestic enterprises can be directly applied for
the manufacturing permit registration. For Class II and Class III
products by domestic enterprises, initial registration can be made
for only trial production, the certificate of which is valid for two
years. Seven months upon trial production registration completion,
application may be made for manufacturing permit registration, the
certificate of which is valid for 4 years.
Formation
of the registration number:
X1
YGX (X2 ) XXXX3 No. X4XX5XXXX6
X
1 is the abbreviation for the location of the registering
agency (national; provinces, autonomous regions or municipalities
directly under the central government; or province, autonomous
region plus municipality divided into districts);
X2
is the type of registration (trial production or manufacturing
permit).
XXX
X3 is the year of registration.
X4
is the product classification.
X
X5 (for trial production) is the date of expiration of
registration and
(for
manufacturing permit) is the code for the product variety.
XXX
X6 is the registration serial number.
The
registration certificate is attached with Medical Device Product
Manufacture Recognition Form, which is to be used with the
registration certificate.
(2)
Product Registration Certificate for products manufactured by
enterprises outside the borders of China is valid for four years.
Formation
of the registration number:
SDA
(I) XXX X1No. X2 X X3XXXX4
XXX
X1 is the year of registration.
X2
is the product classification.
X
X3 is the code for the product variety
XXX
X4 is the registration serial number.
The
registration certification is attached with the Registration Form
for Medical Device, which is to be used with the registration
certificate.
Chapter II
Registration of Domestic Medical Device
Article
5 For the
registration of Class I medical device manufactured by domestic
enterprises, the manufacturing enterprise must submit the following
documentation:
1. Qualification
certification for medical device manufacturing enterprise.
2. Product
specifications and explanation of their determination.
3. Self-test
Report on all the properties and functions of the product
4. Explanation of
the current state of resources available with the enterprise for
product manufacturing and quality control (including testing
methods).
5. Instructions
for use of product.
6. Self-declaration
by the enterprise to guarantee the truthfulness of the documentation
submitted.
Article
6 For the
registration of Class II and Class III medical device manufactured
by domestic enterprises for trial production, the following
documentation must be submitted:
1. Qualification
certification for medical device manufacturing enterprise.
2. Product
technical file.
3. Safety and
risk analysis report.
4. Product
specifications and explanation of their determination.
5. Self-test
Report on all the properties and functions of the product
6. Type test
report issued within 1 year before the registration application for
trial production (biological materials test should be carried out
within 6 months before the start of clinical trials) by a test
center recognized by the State Drug Administration.
7. Clinical
trials report from at least two clinical trial sites. The format of
the reports must be in accordance with the Sub-provisions on
Clinical Trials Report for Medical Device Registration (see
appendix). The clinical trials shall be carried out in accordance
with the Provision on Medical Device Clinical Trials.
8. Instructions
for use of product.
9. Self-declaration
by the enterprise to guarantee the truthfulness of the documentation
submitted.
Article
7 For the
registration of Class II and Class III medical device manufactured
by domestic enterprises for trial production, the following
documentation must be submitted for manufacturing permit, the
manufacturing enterprises must submit the following documentation:
1. Qualification
certification for medical device manufacturing enterprise.
2. Copy of trial
production registration certificate.
3. Product
specifications.
4. Product
improvement report during the period of trial production.
5. Valid
certificate for quality system (recognition certificate) of the
enterprise.
6. Type test
report issued within 1 year before the registration application for
manufacturing permit by a test center recognized by the State Drug
Administration.
7. Product
quality tracking report
8. Self-declaration
by the enterprise to guarantee the truthfulness of the documentation
submitted.
Article
8 Six months
before the expiration of product manufacturing permit expiration,
application shall be made to re-register the product.
1. For the
re-registration of Class I medical device, the following
documentation shall be submitted:
1. Qualification
certification for medical device manufacturing enterprise
2. Copy of
previous manufacturing permit
3. Product
specification
4. Product
quality tracking report.
5. Self-declaration
by the enterprise to guarantee the truthfulness of the documentation
submitted.
2. For the
re-registration of Class II and Class III medical device, the
following documentation shall be submitted:
1. Qualification
certification for medical device manufacturing enterprise
2. Copy of
previous manufacturing permit
3. Type test
report issued within 1 year before the registration application for
manufacturing permit by a test center recognized by the State Drug
Administration.
4. Valid
certificate of quality system audit (recognition certificate) of the
enterprise.
5. Product
specifications and explanation of their determination.
6. Product
quality tracking report.
7. Self-declaration
by the enterprise to guarantee the truthfulness of the documentation
submitted.
Article
9 Enterprise
applying for registration of Class II and III medical device
manufacturing permit shall pass quality system audit. Quality system
audit shall be carried out in accordance with the Provisions on
Quality System Audit for Medical Device Manufacturing Enterprises.
Article
10 For
products, which meet either of the following conditions, application
may be directly made for manufacturing permit after supplementary
documentation submission required for product trial application.
1. The
enterprise has already acquired GB/T19001 and YY/T0287 or GB/T19002
and YY/T0288 (Quality System—Special Requirements Applicable to
Medical Device) recognition certificates issued by a quality system
recognition agency designated by the State Drug Administration. In
addition, the product for which registration for manufacturing
permit is being applied must be in the same product type as a
product that has already been registered for manufacturing permit.
2. The
difference in configuration and functions between the product for
which registration for manufacturing permit is being applied and a
similar product that is already registered for manufacturing permit
is insignificant in terms of safety and effectiveness.
Chapter III.
Registration of Medical Device
Manufactured
Outside of China
Article
11 The
following documentation is required for the registration of medical
device manufactured outside of China:
1. Legal
Qualification certification for medical device manufacturing
enterprise
2. Qualification
Certification of applicant.
3. Document
proving that the government in the country of origin (or regions
such as Taiwan, Hong Kong or Macao) has approved the product to be
sold as medical device in the market of that country or region.
4. Product
technical specifications which refer to the requirements for safety
and technical functions of the product to be registered and the
corresponding testing methods (two copies required for Class III
products).
5. Product
instructions for use.
6. Type test
report issued within 1 year before the registration application by a
test center recognized by the State Drug Administration. (applicable
to Class II and Class III products).
7. Medical device
clinical trials report. The format of the reports must be in
accordance with the Sub-provisions on Clinical Trials Report for
Medical Device Registration (see appendix). The clinical trials
shall be carried out in accordance with the Provision on Medical
Device Clinical Trials.
8. Product
Quality Guarantee issued by the manufacturer certifying that the
quality of the product to be registered for sale in China is exactly
the same as that of the product marketed in the country (region) of
origin.
9. Letter of
Authorization for designated after-sales service agency in China and
Letter of Undertaking and business license of the authorized agency
10. Self-declaration
by the enterprise to guarantee the truthfulness of the documentation
submitted.
The
above documentation shall have Chinese versions. Copies of
documents, which must carry the signature and stamp of the issuing
agency or be notarized by local notarized body, may be submitted for
Item 1 through 3. All other documents must be the originals and
carry the seal or signature of the legal representative of the
enterprise
Article
12 Six
months before the expiration of the registration certificate for
imported medical devices, the following documentation needs to be
submitted for product re-registration:
1. Qualifications
certificate of the applicant.
2. Copy of old
registration certificate.
3. Document
proving that the government in the country of origin (or region) has
approved the product to be sold as medical device in the market of
that country or region.
4. Product
technical specifications which refer to the requirements for safety
and technical functions of the product to be registered and the
corresponding testing methods (two copies required for Class III
products).
5. Product
instructions for use. Type test report issued within 1 year before
the registration application by a test center recognized by the
State Drug Administration. (applicable to Class II and Class III
products).
6. Product
quality tracking report.
7. Product
Quality Guarantee issued by the manufacturer certifying that the
quality of the product to be registered for sale in China is exactly
the same as that of the product marketed in the country (region) of
origin.
8. Letter of
Authorization for designated after-sales service agency in China and
Letter of Undertaking and business license of the authorized agency
9. Self-declaration
by the enterprise to guarantee the truthfulness of the documentation
submitted.
Article
13 An
on-site inspection of the production quality system is required for
registration of Class III medical device manufactured by an
enterprise outside the borders of Mainland China. The cycle time of
on-site inspection of quality system is valid for four years. If the
quality system for the same type of product has been inspected and
approved within the same cycle, the on-site inspection need not be
repeated for new registration application.
Chapter IV
Management of Medical Device Registration
Article
14 The Drug
Administration of the municipalities consisting of districts shall
decide within thirty working days upon receipt of all required
documentation whether or not to approve a registration application.
The
Drug Administration of provincial level shall decide within sixty
working days upon receipt of all required documentation whether or
not to approve a registration application.
The
State Drug Administration shall decide within ninety working days
upon receipt of all required documentation whether or not to approve
a registration application (exclusive of the time required to carry
out an overseas on-site inspection of the quality system).
A
written explanation of rejection reasons shall be issued for an
application rejection.
Registration
acceptance department shall issue Acceptance Notification
upon receipt of full documentation and start the time count for
documentation evaluation period.
If
the applicant is informed to provide additional documentation or
clarification of a certain question during documentation evaluation,
the time required to respond to the request is not included in the
time count for documentation evaluation period.
Article
15 An
enterprise may apply for an exemption from type test if the applied
medical device meets all of the following conditions:
1. For a
domestic enterprise, the enterprise has already acquired GB/T19001
and YY/T0287 or GB/T19002 and YY/T0288 recognition certificates
issued by a quality system recognition agency designated by the
State Drug Administration. In addition, the approved quality system
covers the product being applied for registration.
For
a product manufactured by an enterprise in another country or
region, the enterprise has received and still has a valid market
approval from the government agency of country of origin. In
addition, the enterprise has acquired the recognition of its quality
system based on ISO 9000 (or equivalent) series standard.
2. The
difference in configuration and functions between the applied
product and a similar product that is already registered is
insignificant in terms of safety and effectiveness.
2. The product
being applied is not an implantable device.
3. The product
being applied does not contain radiation source.
4. The
malfunction of the product, if any, shall not result in death or
serious injury to the user or operator of the product.
Article
16 The
instructions for use of the product should be examined and approved
according to Provisions on Instructions for Use, Labeling and
Packaging Indication of Medical Device. Upon approval of the
instructions for use, no unauthorized amendment is permitted. Adding
indication for use or expanding the scope of product application
shall require a new application for registration.
Article
17 The
classification medical device registration unit shall be based the
differences in product technical configuration and functional
specifications.
Article
18 For a
product, which meant to be used in conjunction with other devices,
registered as a component, the enterprise shall state the
specifications or model number of recommended products, components
or assemblies to be used together. For an assembly consists of
components that have already been registered individually, the
entire assembly shall be re- registered as a system.
For
an assembly of components registered as a system, a list of main
components shall be provided. In the case of any change in the
specifications of one of the components, application shall be made
to re-register the entire system.
If
a component of an assembly that is registered as a system is to be
sold separately, it does not require a separate registration.
Article
19 The
procedures for amendment or supplementing a registration certificate
are as below shown:
1. In the case
of manufacturing enterprise name change or merge with another
enterprise, etc., change of enterprise name in the registration
certificate is required. The application letter, the new business
license and the certificate from the local drug administration shall
be submitted to complete the registration certificate amendment
procedures within 30 working days of the change.
2. In case of
product name change, but no change in the product itself, an
application letter needs to be submitted to complete completed to
registration certificate amendment procedures.
3. In the case
of loss or damage of the registration certificate, an application
letter and a declaration of legal liability undertaking shall be
submitted to apply for a new registration certificate.
4. Manufacturing
site change, though with no change in the company or the product
itself, is not covered in the scope applicable to registration
certificate alternation. The product shall be re-registered
following the same procedures as its previous registration. A valid
certification for production quality system audit (recognition) is
required to be submitted for the registration application.
Article
20 If a
registration certificate is altered, the original number is adopted
with the word “amendment” in parentheses added at the end of the
original number to indicate the alternation. The date of issue shall
be the date the amendment is approved and the term of validity will
be the same as the original registration, specified as “expires YY/MM/DD.”
The original registration certificate shall be retracted when a new
certificate is issued.
Article
21 The
registration certificate is automatically invalidated if a medical
device is out of production for over two consecutive years. If the
enterprise intends to resume production, the product shall have to
be re-registered.
Article
22 The
management of the registration of medical device acquired from
re-sale is covered under other provisions.
Article
23 A medical
institution may develop medical devices for patient treatment, but
the device cannot be mass manufactured during the research and
development period. Such devices can only be used within the
institution where it was developed and the institution shall receive
a product use permit with the validity for two years. The
institution shall apply for registration for manufacturing permit
upon expiration of use permit according to registration evaluation
and approval procedures.
Application
for Class II products should be submitted to drug administration of
provincial level and application for Class III products should be
submitted to the State Drug Administration. The following
documentation shall be submitted for the application:
1. Qualification
certificate of the medical institution.
2. Product
specifications.
3. Type test
report issued within 1 year before the registration application by a
test center recognized by the State Drug Administration.
4. Clinical
trials Report
5. Instructions
for use.
6. Declaration
of legal liability undertaking for the product from the hospital.
7. Self-declaration
to guarantee the truthfulness of the documentation submitted.
Article
24 All the
drug administration of the municipalities consisting of districts
shall submit a report to drug administration of the provincial level
every three months for product registration statistics. All drug
administration of provincial lev el shall submit a report to the
State Drug Administration every three months for product
registration statistics. The State Drug Administration shall
regularly publish medical device registration bulletin.
Chapter Ⅴ
Penalties
Article
25 If a
registratio n of medical device is obtained in violation of this
provision by submitting a false certificate, document or sample or
through any other fraudulent means, the original registration agency
shall revoke the registration and not accept another registration
application of that enterprise in the next two years. A fine will
also be levied in accordance with the relevant articles of the
Provision on the Supervision and Management of Medical Device.
Article
26 If an
enterprise changes the instructions for the use of the product by
enlarging product applicable scope or indication for use without
authorization, such case shall be handled in accordance with Article
35 of Provision on the Supervision and Management of Medical Device.
The violation is considered as manufacturing medical device without
registration for manufacturing permit, and the original registration
agency shall revoke the product registration.
Article
27 If the
applicant has disputes about the conclusion of medical device
registration evaluation, the applicant may submit application
requesting for documentation re-examination within thirty working
days upon receipt of the decision notice. The request shall specify
the application number of the original application, the product name
and the name of the manufacturer and the reason for the request for
application re-examination as well as relevant documents and
samples.
Article
28 If it is
discovered that the safety or effectiveness of a post-market medical
device can not be ensured, drug administration of provincial level
or above shall revoke the registration certificate according to the
corresponding regulations. Those medical devices, the registration
of which have been revoked, must not be manufactured, sold or used.
The local drug administration shall be held responsible for the
supervision and disposal of the devices already manufactured or
used.
Article
29 The State
Drug Administration has the right to order a local administration
(provincial level or lower) to make corrections within a certain
period of time in cases where the state bureau determines that
registration is handled in violation of this provision. If such
correction is not made within the specified time limit, the state
administration may directly announce the revocation of the
registration certificate that was illegally registered.
Chapter VI
Supplementary Articles
Article
30 The State
Drug Administration reserves the right to interpret this provision.
Article
31 This
provision goes into effect April 10, 2000 in conjunction with the
abolishment of the original Decree No. 16 of the State Drug
Administration, Provision on the Medical Device Registration.
Appendix:
Sub-provisions
on the Clinical Trials Report for the Medical Device Registration
Sub-provisions
on the Clinical Trials Report for the Medical Device Registration
|
Product
Classification
|
Basic
Scenarios
|
Conditions
|
Clinical
Report Providing Modes
|
|
Class
III Product
|
1.
All Scenarios
|
Product
has not been approved for sale in the country of origin.
|
Document
approving clinical trials within the borders of China,
clinical trial protocol and clinical trial report.
|
|
Class
III Implantable Device
|
2.
Enterprise has never before had a product marketed in China
|
Product
manufactured in China has not been approved for sale in China;
product manufactured outside of China has been approved for
sale in the country of origin.
|
Document
approving clinical trials within the borders of China,
clinical trial protocol and clinical trial report.
|
|
|
3.
Enterprise already has products in the Chinese market.
|
A.
Meets both conditions:
1.
Product manufactured in China has not been approved for sale
in China; product manufactured outside of China has been
approved for sale in the country of origin.
2. The Chinese government has audited the quality system of
the enterprise, but the applied product is not covered.
|
For
product manufactured in China, clinical trial report in
accordance with relevant regulations.
For product manufactured outside of China, the clinical trial
report submitted at the time of registration application for
market in country of origin, recognized by a team of
specialists organized by the Chinese government.
|
|
Product
Classification
|
Basic
Scenarios
|
Conditions
|
Clinical
Report Providing Modes
|
|
|
|
B.
Meets all conditions:
1.
Product manufactured in China that has not been approved for
sale in China; product manufactured outside of China has been
approved for sale in the country of origin
2. Valid recognition by Chinese government for enterprise’s
quality system that covers applied product
3. No complaints recorded against other products of the
enterprise with a sale history in China for at least four
years.
Note:
If a complaint has been filed, item A shall be applied.
|
For
product manufactured in China, clinical trial report in
accordance with relevant regulations.
For product
manufactured outside of China, the clinical trial report
submitted at the time of registration application for market
in country of origin.
|
|
|
4.
Enterprise already has products in the Chinese market; applied
product and product already registered belongs to the same
product type but different models.
|
A.
Meets both conditions:
1.
Product manufactured in China has not been approved for sale
in China; product manufactured outside of China has been
approved for sale in the country of origin.
2. The Chinese government has audited the quality system of
the enterprise, but the applied model is not covered.
|
For
product manufactured in China, clinical trial report in
accordance with relevant regulations.
For product manufactured outside of China, the clinical trials
report of product of the same type submitted at the time of
registration application for market in country of origin,
recognized by a team of specialists organized by the Chinese
government.
|
|
Product
Classification
|
Basic
Scenarios
|
Conditions
|
Clinical
Report Providing Modes
|
|
|
|
B.
Meets all conditions:
1.
Product manufactured in China that has not been approved for
sale in China; product manufactured outside of China has been
approved for sale in the country of origin
2. Valid recognition by Chinese government for enterprise’s
quality system that covers applied product
3. No complaints recorded against other products of the
enterprise with a sale history in China for at least four
years.
Note:
If a complaint has been filed, item A shall be applied. For
product manufactured in China, clinical trial report submitted
for registration for product of the same type manufactured by
enterprise.
For product
manufactured outside of China, the clinical trial report of
product of the same type submitted at the time of registration
application for market in country of origin.
|
|
|
5.
Enterprise already has products in the Chinese market; applied
product and product already registered belongs to the same
model but with different specifications.
|
A.
Meets both conditions:
1.
Product manufactured in China has not been approved for sale
in China; product manufactured outside of China has been
approved for sale in the country of origin.
2. The Chinese government has audited the quality system of
the enterprise, but the applied specification is not covered.
|
For
product manufactured in China, clinical trial report in
accordance with relevant regulations.
For product manufactured outside of China, the clinical trials
report of product of the same family submitted at the time of
registration application for market in country of origin,
recognized by a team of specialists organized by the Chinese
government.
|
|
|
Product
Classification
|
Basic
Scenarios
|
Conditions
|
Clinical
Report Providing Modes
|
|
|
|
B.
Meets all conditions:
4.
Product manufactured in China that has not been approved for
sale in China; product manufactured outside of China has been
approved for sale in the country of origin
5. Valid recognition by Chinese government for enterprise’s
quality system that covers applied product
6. No complaints recorded against other products of the
enterprise with a sale history in China for at least four
years.
Note:
If a complaint has been filed, item A shall be applied.
|
For
product manufactured in China, clinical trial report submitted
for registration for product of the same type manufactured by
enterprise.
For product
manufactured outside of China, the clinical trial report of
product of the same type submitted at the time of registration
application for market in country of origin.
|
|
Other
Class III Product
|
6.
Enterprise has never before had a product marketed in China
|
Product
is not approved for sale on Chinese market, but has been
approved for sale in the original country of manufacture.
|
For
product manufactured in China, clinical trial report submitted
for registration for product of the same type manufactured by
enterprise.
For product
manufactured outside of China, the clinical trials report of
the product submitted at the time of registration application
for market in country of origin, recognized by a team of
specialists organized by the Chinese government.
|
|
Product
Classification
|
Basic
Scenarios
|
Conditions
|
Clinical
Report Providing Modes
|
|
|
7.
Enterprise already has products in the Chinese market, but
applied product is the first time to enter Chinese market.
|
A.
Meets both conditions:
1. Product manufactured in China that has not been approved
for sale in China; product manufactured outside of China that
has been approved for sale in the country of origin.
Therapeutic equipment that uses ultrasound microwaves lasers,
X-rays, gamma rays or other ionic radiation sources.
|
For
product manufactured in China, clinical trial report submitted
for registration for product of the same type manufactured by
enterprise.
For product manufactured outside of China, the clinical trials
report of the product submitted at the time of registration
application for market in country of origin, recognized by a
team of specialists organized by the Chinese government.
|
|
|
|
B.
Meets all conditions:
1. Product manufactured in China that has not been approved
for sale in China; product manufactured outside of China that
has been approved for sale in the country of origin.
2. Diagnostic equipment or therapeutic equipment that does not
use ultrasound microwaves lasers, X-rays, gamma rays or other
ionic radiation sources.
3. No complaints recorded against other products of the
enterprise with a sale history in China for at least four
years.
Note:
If a complaint has been filed, item A shall be applied.
|
For
product manufactured in China, clinical trial report submitted
for registration for product of the same type manufactured by
enterprise.
For product
manufactured outside of China, the clinical trials report of
the product submitted at the time of registration application
for market in country of origin
|
|
Product
Classification
|
Basic
Scenarios
|
Conditions
|
Clinical
Report Providing Modes
|
|
|
8.
Enterprise already has products in the Chinese market; applied
product is in the same product type as the product already
registered in China.
|
A.
Meets both conditions:
1. Product manufactured in China that has not been approved
for sale in China; product manufactured outside of China that
has been approved for sale in the country of origin.
2. Therapeutic equipment that uses ultrasound microwaves
lasers, X-rays, gamma rays or other ionic radiation sources.
|
For
product manufactured in China, clinical trial report submitted
for registration for product of the same type manufactured by
enterprise.
For product manufactured outside of China, the clinical trials
report of the product submitted at the time of registration
application for market in country of origin, recognized by a
team of specialists organized by the Chinese government.
|
|
|
|
A.
Meets both conditions:
1. Product manufactured in China that has not been approved
for sale in China; product manufactured outside of China that
has been approved for sale in the country of origin.
B. No complaints recorded against other products of the
enterprise with a sale history in China for at least four
years.
C. If a complaint has been filed, item A shall be applied.
|
Clinical
trial report submitted for registration of product of the same
type of the enterprise.
|
|
Class
II Products
|
1.
All scenarios
|
Product
manufactured in China that has not been approved for sale in
China; product manufactured outside of China that has not been
approved for sale in the country of origin.
|
Document
approving clinical trials within the borders of China,
clinical trial protocol and clinical trial report.
|
|
|
2.
First time for the product enter the Chinese market
|
A.
Product manufactured outside of China that has been approved
for sale in the country of origin
|
The
clinical trial report submitted at the time of registration
application for market in country of origin.
|
|
Product
Classification
|
Basic
Scenarios
|
Conditions
|
Clinical
Report Providing Modes
|
|
|
|
B.
For product manufactured in China, product of the dame type of
the enterprise already approved for sale in Chinese market
with a sales history of at least two years.
|
Clinical
trial report submitted for registration of product of the same
type of the enterprise.
|
Notes:
1. “Same
type” refers to a product that is same in terms of basic
principles, major functions and structure.
2. “Same
model” means that in addition to the above, the basic principles
and structure of the auxiliary functions are same as well.
3. “Same
specifications” means that, in addition to the conditions of notes
1 and 2 above, the performance parameters and indices of the product
are the same.
4. “Complaints”
refers to an adverse accident, the cause of which determined as
product quality through technical means, that the drug
administration of the state, provincial or municipal level accepts
and handles.
5. “Product”
refers to medical device.
BACK |